For the study, the researchers mined published papers about Covid-19 patients for data about the sequence of the antibodies they produced.
A study by researchers at the Barcelona Institute for Global Health (ISGlobal), found that people who were infected by SARS-CoV-2, the virus causing Covid-19, had lower levels of HCoV antibodies
Researchers from the University of Padua (Italy) and the Imperial College London tested more than 85 per cent of the 3,000 residents of Vo' in Italy, in February/March 2020 for infection with SARS-CoV-2
Lower antibody count after jab does not mean poor immunity, say experts
Members of the Foundation presented demonstrations by holding placards at Telangana Chowk
The team from the University of Texas at Austin analysed blood plasma samples from four people who recovered from SARS-CoV-2 infections.
The small study, published in the American Journal of Obstetrics and Gynaecology, analysed the blood of 27 pregnant women who had received either the Pfizer or Moderna vaccine in their third trimester
The woman, who has been breastfeeding the baby exclusively, received the second dose of the vaccine as per the normal 28-day vaccination protocol timeline.
"We were able to leverage the unique high-throughput capacity that was already in place and apply it to SARS-CoV-2," said researcher Alejandro Balazs from Massachusetts General Hospital in the US.
The study showed that 54 per cent of the population in the city has antibodies, which means they have developed immunity to SARS-CoV-2 virus
The sero-prevalence at the national level went up 3.1 times between August and December but in Telangana, this went up by two times
We utilized the latest advances in materials and manufacturing such as nanoparticle 3D printing to create a device that rapidly detects Covid-19 antibodies," said researcher Rahul Panat, Associate Professor at Carnegie Mellon
The findings which were published in Science Immunology identifies new links between the course of the disease and a patient's immune response to it
The results of the study also revealed that antibodies were not only in sufficient numbers, but also strong, when the plasma was donated within 12-53 days post recovery.
Bharat Biotech stated it is an innovator, vaccine developer and manufacturer and safety of vaccines is its primary objective, followed by efficacy
12Page 1 of 2
- Advertisement -